Supplementary Data from Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Data from Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
Authors: Frits van Rhee, Susann M. Szmania, Myles Dillon, Anne M. van Abbema, Xin Li, Mary K. Stone, Tarun K. Garg, JuMei Shi, Amberly M. Moreno-Bost, Rui Yun, Balaji Balasa, Bishwa Ganguly, Debra Chao, Audie G. Rice, Fenghuang Zhan, John D. Shaughnessy, Bart Barlogie, Shmuel Yaccoby, Daniel E.H. Afar
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361813552